Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
MVASI bevacizumab 400 mg/16 mL injection concentrated vial, Amgen Australia Pty Ltd, CON-1009
Product name
MVASI bevacizumab 400 mg/16 mL injection concentrated vial
Sponsor name
Amgen Australia Pty Ltd
Consent start
Consent no.
CON-1009
Standard
Paragraph 8(1)(i) of the Therapeutic Goods Order No.91 '“ Standard for labels of prescription and related medicines (TGO 91).
Non-compliance with standard
The product labels do not comply with the paragraph 8(1)(i) of TGO 91 in that,
on the cartons the contact details of the distributor of the medicine are not
current.
Therapeutic product type
Prescription medicines